Skip to content

Home
Receipts
Watchlist

About
Get involved

Privacy first · Built by HelloJoal · assisted by AI

Home
Receipts
Watchlist

SB 2818

Senate·16th Congress·Filed Jun 8, 2015

Annual Marketing Expenses Report for Drug Manufacturers Act

An Act to Require Manufacturers or Labelers of Prescription Drugs to Report Their Annual Marketing Costs

Status

Live status tracking covers the 20th Congress only. See the official record below for this bill’s final outcome.

Author · Senator

Miriam Defensor Santiago
SenatorMiriam Defensor Santiago
Receipts →

Author · Senator

Miriam Defensor Santiago
SenatorMiriam Defensor Santiago
Receipts →

Subjects

Label/LabelingDrug LabelingMedicines/Drugs

Official sources

Senate record
Bill text (PDF)

Spot something wrong?

Printed from CivicSync PH: https://civicsync-ph-gamma.vercel.app/bills/01K67YJE9CPZR7NC6ACDQACJ9G. Status changes over time; check the link for the latest.

SBN-02818 · Sources: BetterGov Open Congress

SB 2818: Annual Marketing Expenses Report for Drug Manufacturers Act · CivicSync PH

Related bills · 20th Congress

Similar in what they’d do, filed by any lawmaker.

HB 8552· Filed Mar 16, 2026
An Act Strengthening Domestic Pharmaceutical Manufacturing, Ensuring Medicines Supply Security, and Supporting the Sustainability of Universal Health Care
Pending with the Committee on HEALTH since 2026-03-18Rep. Girlie E. Veloso
HB 3868· Filed Aug 20, 2025
An Act Increasing Access to Cancer and Related Care Medicines by Mandating an Automatic or Expedited Licensing and Registration Process of Antineoplastic Drugs Sourced Overseas, While Ensuring Their Availability at Affordable Prices, Appropriating Funds Therefor, Amending for the Purpose Republic Act No. 11215, Otherwise Known as "National Integrated Cancer Control Act"
Pending with the Committee on HEALTH since 2025-08-27Rep. Stephen James T. Tan
HB 9221· Filed May 12, 2026
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2026-05-18Rep. Florabel C. Yatco
HB 4259· Filed Sep 1, 2025
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2025-09-03Rep. Ferdinand Martin G. Romualdez +3
HB 7582· Filed Feb 3, 2026
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2026-02-09Rep. Eric L. Olivarez